Replies to post #124838 on Biotech Values

[DewDiligence]

…anyone willing to comment on the PR put out by ARNA today?

Today’s jump is a good opportunity to sell, IMO. Current assets are approximately equal to ST + LT liabilities (excluding the deferred revenue line item), so the enterprise value is roughly the same as the market cap and is more than $200M as of today’s close.